Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 June 1993 | Volume 118 Issue 11 | Pages 833-837
Objective: To study the test-ordering behavior of practicing physicians regarding ambulatory monitoring of blood pressure and to assess changes in patient management after this study.
Design: Cross-sectional assessment of physicians' practice habits regarding the ordering of ambulatory blood pressure monitoring and a longitudinal study of patient management after monitoring.
Setting: Physicians' offices in central Connecticut.
Participants: Two hundred thirty-seven consecutive patients referred by 65 community- and hospital-based physicians.
Measurements: Indications for ambulatory blood pressure monitoring, changes in diagnosis and therapy, and office blood pressures before and after the ambulatory blood pressure study.
Results: The main indications for ordering the test included borderline hypertension (27% of studies ordered), assessment of blood pressure control during drug therapy (25%), evaluation for "white coat" or "office" hypertension (22%), and drug-resistant hypertension (16%). After the ambulatory blood pressure study, only 13% of the patients had further testing (for example, echocardiography); the diagnosis was changed in 41% of the patients, and antihypertensive therapy was changed in 46%. In 122 patients for whom data were complete, office blood pressure measured by the referring physician decreased from 161/96 ± 22/12 mm Hg before the ambulatory blood pressure study to 151/86 ± 27/12 mm Hg 3 months after the study (P = 0.004 for systolic blood pressure and P < 0.001 for diastolic blood pressure). One to 2 years after the study, office blood pressure was 149/86 ± 24/12 mm Hg (P > 0.2 compared with 3 months after the study). Seventy-two percent of the patients had a lower office blood pressure within 3 months of the ambulatory blood pressure study.
Conclusions: Practicing physicians use ambulatory blood pressure recordings for appropriate indications, and data from the monitoring studies affected the management of patients with hypertension.
ARTICLE
Management of Hypertension after Ambulatory Blood Pressure Monitoring
Practicing physicians have recently recognized the utility of ambulatory blood pressure monitoring in clinical practice [1]. The monitors can record many blood pressure measurements during a 24-hour period, thereby providing practicing physicians with a more comprehensive perspective on blood pressure than might be available from office (or casual) blood pressure measurements. The ambulatory blood pressure profile improves the detection rate for clinically significant blood pressure changes that may go undetected during a brief daytime visit to the physician's office [1, 2]. Furthermore, ambulatory blood pressure measurements have been shown to be superior to office measurements for predicting hypertensive target organ damage [3, 4]. Recently, a report from the National High Blood Pressure Education Program Working Group on Ambulatory Blood Pressure Monitoring [1] suggested that ambulatory blood pressure monitoring is appropriate for the evaluation of several clinical situations relating to hypertension Table 1 because of its potential to provide important information not obtainable by office readings.
|
Most practicing physicians do not own ambulatory blood pressure recorders and therefore probably obtain this service through a local hospital or clinic. Ambulatory blood pressure referrals to our hypertension unit have increased markedly in recent years. However, the effects of ambulatory blood pressure on clinical hypertension management by the referring physician remain unknown. To our knowledge, no previous study has been done to determine the influence of data from ambulatory blood pressure monitoring on physicians' practice habits regarding management of hypertensive patients. Thus, our study addressed physicians' ordering of ambulatory blood pressure monitoring and the effects of the information on patient management and office blood pressure control.
Methods
|
|---|
|
|
|---|
All patients with complete 24-hour ambulatory blood pressure reports generated by the University of Connecticut's Section of Hypertension and Vascular Diseases between January 1989 and May 1992 were included in the study. Referrals from the hypertension unit and the author's (WBW) practice were excluded. Referrals came from either hospital-based physicians or physicians in private or community practice in central Connecticut (Figure 1). Our service was not advertised; referrals for clinical studies came via word of mouth. During the study period, a standard instrument (Accutracker II, Suntech Medical Instruments, Raleigh, North Carolina) [5] was used for all recordings, and a standardized two-page consultative report was generated and sent to the referring physician. The report, prepared by members of our section, included patient demographic characteristics, summary statistics for average 24-hour, "waking" and "sleeping" blood pressures, blood pressure load [6], percentage change in waking and sleeping blood pressures and heart rates, customized blood pressure and heart rate graphs, and a brief clinical impression of the 24-hour profile. The analysis was derived from data obtained from the Accutracker II, which was programmed to record the blood pressure and heart rate at 15-minute intervals from 0600 h to 2200 h and at 30-minute intervals from 2200 h to 0600 h. Detailed activities, symptoms, and medication dosing times were recorded in journals as previously described [3, 7].
|
Study Questionnaires
We developed two questionnaires for each referring physician. We used a general questionnaire to assess physicians' demographic characteristics, practice specialty, and familiarity with ambulatory blood pressure monitoring; the clinical diagnoses they considered appropriate for monitoring a patient; and their level of confidence in the precision of the test and expected future use of ambulatory blood pressure monitoring.
A second questionnaire focused on the management of physicians' referred patients. This questionnaire was used to evaluate how the results of ambulatory blood pressure monitoring affected patient management in terms of additional diagnostic test ordering and changes in diagnosis and antihypertensive therapy. The office blood pressure readings determined by the referring physician before ambulatory blood pressure monitoring, within 3 months after testing, and within 1 to 2 years after testing, were requested through the data questionnaires and follow-up telephone calls, if necessary.
Statistical Analyses
Comparisons of the responses of hospital-based and community-based physicians on the questionnaires were done using chi-square analysis. Statistical comparison of the office systolic and diastolic blood pressures before and after ambulatory blood pressure monitoring was done using analysis of variance. Tests for normality of blood pressure distributions were done using the Shapiro-Wilk test.
Results
|
|---|
|
|
|---|
Physicians' Use of Monitoring
Most ordering physicians were internists (57%); clinical cardiologists formed the second largest group (see Figure 1). The physicians indicated awareness of ambulatory blood pressure monitoring for an average of 4.3 years. Sixty-one percent of the community-based physicians felt well informed about ambulatory blood pressure monitoring, whereas only 28% of the hospital-based physicians placed themselves in that same category [P = 0.02]. Seventy-seven percent of the entire physician group indicated they had learned about ambulatory blood pressure monitoring through journal articles, 66% through discussion with colleagues, 58% through lectures and conferences, and 43% through the ambulatory blood pressure monitoring report.
The hospital-based physicians said they would order an ambulatory blood pressure study to aid in the diagnosis of "white-coat" or "office" hypertension, borderline hypertension, severe hypertension, and symptomatic hypertension and to assess antihypertensive therapy and blood pressure control. Similar findings were noted among the community-based physicians, who showed a greater tendency to order an ambulatory blood pressure monitoring study in cases of suspected "white coat" or "office" hypertension (P = 0.03) or borderline hypertension or in cases in which assessment of drug therapy was indicated.
Physicians in both types of practice indicated they felt confident in the precision of the 24-hour ambulatory monitoring devices (80% of total group). After recent experiences with ambulatory blood pressure monitoring, 24% of the physicians indicated they would probably use the test more often, 4% indicated they would use the test less often, and 68% indicated they would order the test with approximately the same frequency as in the recent past.
Of 237 patients who underwent ambulatory blood pressure monitoring, 22% were studied for suspected "white coat" hypertension, 27% for borderline hypertension, 25% for assessment of antihypertensive therapy and control of pressure, and 16% for drug-resistant hypertension (Figure 2). Questionnaires for individual patients were completed (including office blood pressure data) for 122 patients referred by 37 of the hospital- and community-based physicians. The average age of these patients was 56 ± 6 years; 51% were men, and 65% were receiving antihypertensive therapy at the time of the ambulatory blood pressure study. Physicians had referred an average of 3.3 patients to the ambulatory blood pressure monitoring laboratory, and the mean duration that a patient had been under the care of the referring physician was 6.6 ± 3.4 years.
|
Changes in Patient Management
The influence of the ambulatory blood pressure monitoring results on patient management was assessed by evaluating test-ordering behavior and changes in diagnosis and therapy. Only 6 of the 47 physicians (13%) ordered additional tests (exercise testing, 3%; echocardiography, 7%; and angiography, 3%) based on monitoring results. Forty-three percent of the hospital-based physicians and 38% of the community-based physicians altered their diagnosis based on data provided by ambulatory blood pressure monitoring. In patients with variable, borderline hypertension, the most common new diagnoses were "white coat" hypertension (40%) and sustained hypertension (26%). Twenty-two percent had a diagnosis that was categorized as sustained hypertension while receiving drug therapy with a "white-coat" component (that is, patients whose out-of-office blood pressure measurements were substantially lower, albeit abnormal, when compared with their office measurements).
Antihypertensive therapy was changed in 53% of the hospital-based physicians' patients and in 34% of the community-based physicians' patients based on information provided by the ambulatory blood pressure monitoring study. Overall, 88 patients had changes in their treatment regimen. Nearly one third of the 88 patients initially received antihypertensive therapy because of the findings from monitoring (Table 2).
|
Changes in Blood Pressure
We compared office blood pressure readings obtained before monitoring with office readings obtained within 3 months and within 1 to 2 years after monitoring. Before the ambulatory blood pressure monitoring study, the mean office blood pressure was 161/96 ± 22/12 mm Hg and was normally distributed (Figure 3). Three months after ambulatory blood pressure monitoring, the mean office blood pressure fell 13/10 ± 3/2 mm Hg (P = 0.004 for systolic blood pressure; P < 0.001 for diastolic blood pressure). The distribution of the changes in office blood pressure is shown in Figure 4. The office blood pressure of most patients was lower after the procedure. One to 2 years later, these changes in office blood pressure had stabilized: At that time, blood pressure was 15/10 ± 3/2 mm Hg lower when compared with the prestudy measurement and 2/0 ± 1/1 mm Hg lower when compared with the measurement obtained within 3 months after monitoring (P > 0.3 for both systolic and diastolic pressure).
|
|
Seventy-two percent of the 122 patients had a lower (defined by a decrease of more than 10 mm Hg in either systolic or diastolic blood pressure) office blood pressure 3 months after the ambulatory blood pressure study. In this subgroup, 41% had a change in their antihypertensive regimen: Seventeen percent were given an antihypertensive agent, 12% received an additional agent or had a dose increase in existing medication, and 12% had a substitution in medication.
Discussion
|
|---|
|
|
|---|
Ambulatory blood pressure monitoring appeared to affect the management of the patients in our study: Forty-one percent of the patients underwent a change in diagnosis and 46% had some sort of change in antihypertensive therapy after ambulatory blood pressure monitoring (see Table 2). As expected, many of the patients had their diagnosis changed to "white coat" hypertension or to sustained hypertension with a "white coat" component. In some instances, these patients may have been spared unnecessary or excessive medication, a change in lifestyle, and the psychological effects of being labeled "hypertensive" [1].
The high percentage of patients receiving antihypertensive therapy who were referred for an ambulatory blood pressure study (65%) was surprising. Waeber and colleagues [13] reported that some patients with symptomatic hypertension receive excessive treatment; however, many patients in our study had inadequate blood pressure control, and office blood pressures were lower after monitoring studies (see Figure 4). This finding suggests the unexpected benefit of ambulatory blood pressure monitoring for detection of persons with poorly controlled hypertension; one might speculate that improved blood pressure control in such patients could yield reduced target organ involvement [4, 6, 14].
Ambulatory blood pressure monitoring may be useful in several clinical situations related to hypertension management (see Table 1). Physicians in practice appear to be adhering to general recommendations of the Working Party Report for these indications and have not demonstrated abuse of this study. However, because the physicians in our study did not receive remuneration for ordering this test, this finding is not necessarily applicable to a scenario in which ambulatory blood pressure monitoring is widely approved by third-party insurance carriers.
Our study had several limitations. First, the study did not include controls who were evaluated and treated without ambulatory blood pressure monitoring. The reductions in office blood pressure (see Figure 4) may be related to the ambulatory blood pressure data, but without a control group, the direct relevance is unknown. Second, although the general outcome in our patient population was positive, these findings cannot be extended to the general population of hypertensive patients. Referring physicians probably were having diagnostic or therapeutic challenges with their patients. Some physicians may have already been poised to make therapeutic changes in their patients, and, although the monitoring helped with that decision, other clinical issues were probably part of the physician's decision-making process.
The many readings provided by ambulatory blood pressure monitoring during activities of daily living are superior to the casual readings taken in the doctor's office for the detection and evaluation of specific types of hypertensive problems [1]. However, recommendations for use of ambulatory blood pressure monitoring have been tempered by the fact that only one prognostic study [15] has shown any relationship between ambulatory blood pressure and cardiovascular risk. The main effects of ambulatory blood pressure monitoring on blood pressure management include more precision in diagnosis and significant, albeit indirect, improvement in hypertension control. Our findings, as well as other published studies, should stimulate investigators to examine whether ambulatory blood pressure monitoring changes the outcome of care and whether its use is cost-effective.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. National High Blood Pressure Education Program Working Group report on ambulatory blood pressure monitoring. Arch Intern Med. 1990; 150:2270-80.
2. Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH. Blood pressure during normal daily activities, sleep, and exercise in normal and hypertensive subjects. JAMA. 1982; 247:992-6.
3. White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA. 1989; 261:873-7.
4. White WB. Ambulatory blood pressure and target organ involvement in hypertension. Clin Invest Med. 1991; 14:224-30.
5. White WB, Lund-Johansen P, McCabe EJ, Omvik P. Clinical evaluation of the Accutracker II ambulatory blood pressure monitor: assessment of performance in two countries and comparison with sphygmomanometery and intra-arterial blood pressure at rest and during exercise. J Hypertens. 1989; 7:967-75.
6. White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J. 1989; 118:782-95.
7. White WB. Assessment of patients with office hypertension by 24-hour noninvasive ambulatory blood pressure monitoring. Arch Intern Med. 1986; 146:2196-9.
8. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh J. How common is white coat hypertension? JAMA. 1988; 259: 225-8.
9. Bass MJ. Ambulatory blood pressure monitoring and the primary care physician. Clin Invest Med. 1991; 14:256-9.
10. White WB, Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. Am J Cardiol. 1989; 63:94-8.
11. Health and Policy Committee, American College of Physicians. Automated ambulatory blood pressure monitoring. Ann Intern Med. 1986; 104:275-8.
12. Krakoff LR, Eison H, Phillips RH, Leiman SH, Lev S. Effects of ambulatory pressure monitoring on the diagnosis and cost of treatment for mild hypertension. Am Heart J. 1988; 116:1152-4.
13. Rion F, Waeber B, Graf HJ, Jaussi A, Porchet M, Brunner HR. Blood pressure response to antihypertensive therapy: ambulatory versus office blood pressure readings. J Hypertens. 1985; 3:139-43.
14. White WB, Schulman P, Karimeddini MK, Smith VE. Regression of left ventricular mass is accompanied by improved left ventricular filling following antihypertensive therapy with metoprolol. Am Heart J. 1989; 117:145-50.
15. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983; 249:2792-8.
Related articles in Annals:
This article has been cited by other articles:
![]() |
I. Z. Ben-Dov, J. D. Kark, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn Predictors of All-Cause Mortality in Clinical Ambulatory Monitoring: Unique Aspects of Blood Pressure During Sleep Hypertension, June 1, 2007; 49(6): 1235 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. White Expanding the Use of Ambulatory Blood Pressure Monitoring for the Diagnosis and Management of Patients With Hypertension Hypertension, January 1, 2006; 47(1): 14 - 15. [Full Text] [PDF] |
||||
![]() |
L. R. Krakoff Cost-Effectiveness of Ambulatory Blood Pressure: A Reanalysis Hypertension, January 1, 2006; 47(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. White Ambulatory Blood-Pressure Monitoring in Clinical Practice N. Engl. J. Med., June 12, 2003; 348(24): 2377 - 2378. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||